We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




‘Molecular Imaging’ Lights up Tumors for Surgeons to Enable Precise Removal

By HospiMedica International staff writers
Posted on 21 Mar 2023
Print article
Image: Lighting up tumors could help surgeons remove them more precisely (Photo courtesy of Pexels)
Image: Lighting up tumors could help surgeons remove them more precisely (Photo courtesy of Pexels)

Neuroblastoma is a devastating form of childhood cancer that accounts for 8-10% of all childhood cancers and roughly 15% of all childhood deaths from cancer. Sadly, in almost one-third of cases, the cancer has already metastasized to other areas of the body at the time of diagnosis, making treatment more challenging. The standard treatment for neuroblastoma involves surgery aimed at removing all cancerous cells, which can be difficult to distinguish from healthy tissue. The procedure carries certain risks, as striking the right balance between removing enough but not too much tumor tissue is crucial. Surgeons need to be careful not to damage surrounding blood vessels, nerves, and other vital organs. Now, a new technique that combines highly-detailed, real-time images of inside the body with a type of infrared light has been successfully used for the first time to differentiate between cancerous tumors and healthy tissue during surgery.

The pioneering technique, demonstrated in mice, that has been developed by engineers at University College London (UCL, London, UK) may have significant implications for treating neuroblastoma in children, which is the most common form of solid cancer tumor, apart from brain tumors, found in children. The scientists utilized a novel method- molecular imaging - during surgery, whereby chemicals were injected into the bloodstream to act as imaging probes. These chemicals are attracted to cancerous cells in the body, and once attached, the probes light up via a process called ‘fluorescence’, thus lighting up the tumor area. The engineers used the technique during preclinical testing in mice to successfully identify part of a tumor that had not been removed during surgery.

In addition, the research team aimed to examine whether it was possible to enhance the visual quality of the images by using short-wave-infrared light (SWIR), which was previously inaccessible to scientists. To achieve this, they utilized a special, high-definition camera for capturing SWIR fluorescence. SWIR remains invisible to the naked eye and has a longer wavelength compared to visible light, enabling it to penetrate deeper into the tissue to provide more detailed and sharper images. In preclinical tests, the technique enabled surgeons to differentiate between healthy and cancerous tissue successfully. Unlike X-ray or MRI, molecular imaging captures detailed photos of biological processes live during surgery. This means that clinical teams no longer need to wait for biopsy or culture results when screening for diseases. The SWIR further enhances these images in real time. The scientists aim to expedite the use of this technology in operating rooms within the next year for the benefit of children with cancerous tumors.

“Pediatric surgical oncology faces an ever-increasing need for novel technologies and devices that can help visualize tumors intraoperatively,” said Dr. Laura Privitera, UCL Great Ormond Street Institute of Child Health. “By using targeted fluorescence-guided surgery, we demonstrate the possibility of safely and specifically delineating tumor margins, allowing its differentiation from surrounding healthy tissue. Fluorescence-guided surgery is a game-changing innovation that will help surgeons to obtain safer and more complete resection. It is exciting to be part of this project, and I look forward to seeing this technology translated into the clinical environment.”

Related Links:
UCL

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Needlefree Closed System Transfer Device
ChemoClave

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.